DOJ | Jotup

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Retrieved on:

Thursday, March 14, 2024

Zio, Advertising, Boston Scientific, J. P. Morgan, Growth, Patient, Subpoena duces tecum, LLP, DOJ, Justice, Marketing, FDA, Court, IRTC, Pharmaceutical industry

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points:

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
Faruqi & Faruqi, LLP also encourages anyone with information regarding iRhythm’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

FINAL DEADLINE REMINDER FOR CMI INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead Plaintiff Deadline in Securities Class Action Lawsuit Filed Against Cummins Inc. (CMI)

Retrieved on:

Thursday, March 14, 2024

Certification, IRS, District court, Lead, CFTC, LLP, COPY, News, RAM, DOJ, CMI, EPA, Fraud, Medicare, Court, Person, Pharmaceutical industry

The action charges Cummins with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points:

The action charges Cummins with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
As a result of Cummins’ s materially misleading statements and omissions to the public, Cummins’ s investors have suffered significant losses.
Kessler Topaz Meltzer & Check, LLP encourages Cummins investors who have suffered significant losses to contact the firm directly to acquire more information.
The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

U. S. Steel Consent Decree for Clairton Plant Incidents Authorized by Environmental Protection Agency and Department of Justice

Retrieved on:

Tuesday, March 26, 2024

United States Steel Corporation (NYSE: X) has received authorization for its multi-million-dollar Consent Decree from the United States Environmental Protection Agency (U.S. EPA) and the United States Department of Justice (DOJ).

Key Points:

United States Steel Corporation (NYSE: X) has received authorization for its multi-million-dollar Consent Decree from the United States Environmental Protection Agency (U.S. EPA) and the United States Department of Justice (DOJ).
The January 2024 Consent Decree with the Allegheny County Health Department, Clean Air Council, and PennEnvironment addressed the Clairton Plant fire in 2018, and power outages at the Plant in 2019 and 2022.
Project funds will be managed and distributed by the Jefferson Regional Foundation and Allegheny County Department of Economic Development.
On March 20, 2024, DOJ issued a letter stating that they had no objections to the Consent Decree.

Gibbs Law Group Files Class Action Lawsuit on Behalf of Healthcare Providers Harmed by Change Healthcare Data Breach

Retrieved on:

Tuesday, March 19, 2024

On March 18, 2024, Gibbs Law Group filed a class action lawsuit against Change Healthcare Inc., Optum, Inc. and UnitedHealth Group Incorporated following a massive data breach that has disrupted critical infrastructure in the U.S. healthcare system since February 21, 2024.

Key Points:

On March 18, 2024, Gibbs Law Group filed a class action lawsuit against Change Healthcare Inc., Optum, Inc. and UnitedHealth Group Incorporated following a massive data breach that has disrupted critical infrastructure in the U.S. healthcare system since February 21, 2024.
The lawsuit was filed on behalf of healthcare providers whose use of Change Healthcare’s services was disrupted due to the data breach and related shutdown of the Change Healthcare computer networks.
Affected healthcare providers have been unable to get paid on claims for medical services they have provided since the breach occurred.
Healthcare providers who believe they were impacted by the Change Healthcare data breach should contact our legal team for a free case evaluation by calling 510-369-0259 or visiting our website: Change Healthcare Class Action Lawsuit .

Community Health Systems, Inc. (CYH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Retrieved on:

Thursday, March 14, 2024

Class Action Lawsuit, Professional Services, Legal, CYH, Community, Community Health Systems, Manager, Community health, News, DOJ, Annual report, Dialysis

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Community Health Systems, Inc. (“Community Health” or “the Company”) (NYSE: CYH).

Key Points:

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Community Health Systems, Inc. (“Community Health” or “the Company”) (NYSE: CYH).
Investors who purchased Community Health securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CYH .
On February 21, 2024, Community Health disclosed in its Annual Report for 2023 that it was under investigation by the U.S. Department of Justice (“DOJ”).
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Gibbs Law Group Files Class Action Lawsuit on Behalf of Consumers Harmed by Change Healthcare Data Breach

Retrieved on:

Wednesday, March 13, 2024

On March 12, 2024, Gibbs Law Group filed a class action lawsuit against Change Healthcare Inc. following a massive data breach impacting the single largest healthcare payment processor in North America.

Key Points:

On March 12, 2024, Gibbs Law Group filed a class action lawsuit against Change Healthcare Inc. following a massive data breach impacting the single largest healthcare payment processor in North America.
Consumers, patients, and healthcare providers who believe they were impacted by the Change Healthcare data breach should contact our legal team for a free case evaluation by calling 510-369-0259 or visiting our website: Change Healthcare Class Action Lawsuit .
On February 21, 2024, a data breach at Change Healthcare resulted in hackers accessing confidential health and personal information of millions of consumers.
Change Healthcare recently confirmed that ransomware group ALPHV, or Blackcat, a group known for healthcare company ransomware attacks, was responsible for the breach, according to the Associated Press.

ADM Provides Update on Audit Committee Led Investigation

Retrieved on:

Tuesday, March 12, 2024

Agriculture, Natural Resources, Sustainability, Environment, Supply Chain Management, Logistics, Transport, Retail, Nutrition, Webcast, Carbohydrate, Security (finance), DOJ, Bank statement, ADM, Annual report, Central Time, Audit committee

ADM (NYSE: ADM) today provided an update with respect to the internal investigation led by the Audit Committee of its Board of Directors regarding certain accounting practices and procedures with respect to ADM’s Nutrition reporting segment, including as related to certain intersegment sales.

Key Points:

ADM (NYSE: ADM) today provided an update with respect to the internal investigation led by the Audit Committee of its Board of Directors regarding certain accounting practices and procedures with respect to ADM’s Nutrition reporting segment, including as related to certain intersegment sales.
“Our strong commitment to compliance and integrity in our financial reporting is evidenced by the diligence and breadth with which the Audit Committee has conducted its internal investigation.
The adjustments related to the Company’s reporting segments do not impact our consolidated statement of earnings.
In a separate release issued today, ADM reported financial results for the quarter and full year ended December 31, 2023.

Lex Machina Releases 2024 Antitrust Litigation Report

Retrieved on:

Thursday, April 4, 2024

Lex Machina, California Department, Agriculture, Latham & Watkins, Research, LexisNexis, Food, Software, MDL, DOJ, Justice, Partner

MENLO PARK, Calif., April 4, 2024 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Antitrust Litigation Report. The report examines antitrust litigation trends in federal district and appellate courts. Focusing on the three-year period from 2021 to 2023, it surveys emerging trends in case filings, venues, judges, law firms, parties, timing metrics, case resolutions, findings, and damages. The report often focuses on different sets of data, e.g., filtering cases in order to provide analytics on general antitrust cases, DOJ/FTC enforcement contested cases, MDL Master cases, antitrust class action cases, and federal appellate cases.

Key Points:

In the last three years, various subsets of antitrust litigation have exhibited a similar case filing pattern consisting of a drop in 2022 followed by a rebound in 2023
MENLO PARK, Calif., April 4, 2024 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Antitrust Litigation Report.
The report examines antitrust litigation trends in federal district and appellate courts.
"Antitrust is a complex area of litigation that includes different subsets of cases as well as significant numbers of MDL cases," said Ron Porter, Lex Machina's antitrust legal data expert and editor of the report.
Register here for a copy of the report: https://pages.lexmachina.com/2024-Antitrust-Report_LP.html
Lex Machina is hosting a webcast to discuss the report on April 4, 2024 at noon ET/9am PT with Anna Rathbun (Partner at Latham & Watkins), Ron Porter (Lex Machina's Legal Data Expert in Antitrust Litigation), and Aria Nejad (Lex Machina's in-house counsel).

Independent Monitor certifies Ericsson's Compliance Program

Retrieved on:

Thursday, March 28, 2024

Certification, Risk management, Monitor, Record, DOJ, FCPA, Book, Management

STOCKHOLM, March 28, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announced that on March 28, 2024, the independent compliance Monitor appointed by the U.S. Department of Justice (DOJ) (in June of 2020 in connection with Ericsson's resolution of historical violations of the Foreign Corrupt Practices Act (FCPA) violations) has certified that Ericsson's anti-corruption compliance program has satisfied requirements and is functioning effectively.

Key Points:

STOCKHOLM, March 28, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announced that on March 28, 2024, the independent compliance Monitor appointed by the U.S. Department of Justice (DOJ) (in June of 2020 in connection with Ericsson's resolution of historical violations of the Foreign Corrupt Practices Act (FCPA) violations) has certified that Ericsson's anti-corruption compliance program has satisfied requirements and is functioning effectively.
This independent certification is a condition to conclusion of the Monitorship and Plea Agreement, currently expected to occur no later than June 2, 2024.
The role of the independent Monitor over the past four years has been to comprehensively review, assess, evaluate and test all aspects of the company's global anti-corruption compliance program and internal controls.
In fulfilling its duties, the independent Monitor team has had full access to the company's Board, executives, employees, global operations and books and records.

Independent Monitor certifies Ericsson's Compliance Program

Retrieved on:

Thursday, March 28, 2024

Certification, Risk management, Monitor, Record, DOJ, FCPA, Book, Management

STOCKHOLM, March 28, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announced that on March 28, 2024, the independent compliance Monitor appointed by the U.S. Department of Justice (DOJ) (in June of 2020 in connection with Ericsson's resolution of historical violations of the Foreign Corrupt Practices Act (FCPA) violations) has certified that Ericsson's anti-corruption compliance program has satisfied requirements and is functioning effectively.

Key Points:

STOCKHOLM, March 28, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announced that on March 28, 2024, the independent compliance Monitor appointed by the U.S. Department of Justice (DOJ) (in June of 2020 in connection with Ericsson's resolution of historical violations of the Foreign Corrupt Practices Act (FCPA) violations) has certified that Ericsson's anti-corruption compliance program has satisfied requirements and is functioning effectively.
This independent certification is a condition to conclusion of the Monitorship and Plea Agreement, currently expected to occur no later than June 2, 2024.
The role of the independent Monitor over the past four years has been to comprehensively review, assess, evaluate and test all aspects of the company's global anti-corruption compliance program and internal controls.
In fulfilling its duties, the independent Monitor team has had full access to the company's Board, executives, employees, global operations and books and records.